Vimarsana
Biggest News Aggregation in the World

Page 31 - Mark Grenon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Grenon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Grenon Today - Breaking & Trending Today

California coronavirus updates: LA County moves out of high COVID-19 infection tier - Vimarsana News

California coronavirus updates: LA County moves out of high COVID-19 infection tier

Los Angeles County has dropped out of the high COVID-19 community level under federal guidelines, as infections and rates of hospitalizations continue to fall, according to the Associated Press.

California coronavirus updates: Can the monkeypox outbreak be stopped? Experts believe it's possible - Vimarsana News

California coronavirus updates: Can the monkeypox outbreak be stopped? Experts believe it's possible

Since May, barely 90 countries have reported more than 31,000 cases of monkeypox, as reported by the Associated Press.

California coronavirus updates: COVID-19 deaths fall by 9% globally - Vimarsana News

California coronavirus updates: COVID-19 deaths fall by 9% globally

The World Health Organization says in its latest weekly pandemic report that the number of coronavirus deaths fell by 9% in the last week while new cases remained relatively stable.

California coronavirus updates: Incoming college students turn to bridge programs to prepare after COVID-19 disruptions - Vimarsana News

California coronavirus updates: Incoming college students turn to bridge programs to prepare after COVID-19 disruptions

After the disruption of online learning, first-year college students are arriving on campuses unprepared for the demands of college-level work, experts say.

California coronavirus updates: Flushed with cash from COVID-19 treatments, Pfizer buys another drug maker - Vimarsana News

California coronavirus updates: Flushed with cash from COVID-19 treatments, Pfizer buys another drug maker

Pfizer is buying sickle cell drug maker Global Blood Therapeutics in an approximately $5.4 billion deal as it looks to accelerate growth after its revenue soared during the pandemic, according to the Associated Press.